Investors
- Announcements
- 2012
- 2011
- 2010
- 15: Financial Calendar 2011
- 14: Prospekt
- 13: Q3 interim report
- 12: Dako brings BioPorto’s kidney injury test to the world market
- 11: BioPorto pre-launches pioneering kidney injury test
- 10: BioPorto completes the subscription of convertible bonds
- 09: Subscription and issue of convertible bonds
- 08: Interim Financial Report for Q2 2010
- 07: BioPorto’s NGAL test approved for use by leading U.S. reference laboratory
- 06: BioPorto’s patent rights for NGAL - opposition to the European patent
- 05: Interim financial report Q1
- 04: Development of Annual General Meeting
- 03: Insider's dealings
- 02: Annual General Meeting
- 01: Annual Report 2009
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- Presentations
- Key Figures
- Financial Calendar 2012
- Analyst coverage
- Company Documents
- News mail
- Contact investor relations
Announcements from 2010
